Fosamprenavir
In the US, Fosamprenavir (fosamprenavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection and Nonoccupational Exposure.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J05AE07
CAS registry number (Chemical Abstracts Service)
0226700-79-4
Chemical Formula
C25-H36-N3-O9-P-S
Molecular Weight
585
Therapeutic Categories
Antiviral agent
Treatment of HIV infection
HIV protease inhibitor
Chemical Names
(3S)-tetrahydro-3-furyl [(α S)-α-[(1R)-1-hydroxy-2-(N¹-isobutylsulfanil=amido)ethyl]phenethyl]carbamate, dihydrogen phosphate (ester) (WHO)
(S)-Tetrahydro-3-furyl{(αS)-α-[(R)-1-(dihydroxyphosphoryloxy)-2-(N-isobutylsulfanilamido) ethyl]phenethyl}carbamat (IUPAC)
Foreign Names
- Fosamprenavirum (Latin)
- Fosamprenavir (German)
- Fosamprénavir (French)
- Fosamprenavir (Spanish)
Generic Names
- fAPV (IS)
- GW 433908 (IS: GlaxoSmithKline)
- VX 175 (IS: Vertex)
- Fosamprenavir Calcium (OS: USAN)
- 908 (IS)
- GW 433908G (IS)
- VX-175 (IS)
Brand Names
- Telzer
GlaxoSmithKline, Mexico - Telzir
GlaxoSmithKline, Colombia; GlaxoSmithKline, Greece; GlaxoSmithKline, Ireland; GlaxoSmithKline, Peru; GlaxoSmithKline, Romania; GlaxoSmithKline, Turkey - Levixa
GlaxoSmithKline, Japan - Lexiva
GlaxoSmithKline, Israel; GlaxoSmithKline, Japan; ViiV Healthcare, United States - Telzir
Glaxo, Latvia; Glaxo Wellcome, Serbia; GlaxoGroup, Netherlands; GlaxoSmithKline, Antigua & Barbuda; GlaxoSmithKline, Argentina; GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Barbados; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bermuda; GlaxoSmithKline, Bahamas; GlaxoSmithKline, Chile; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, Grenada; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Iceland; GlaxoSmithKline, Jamaica; GlaxoSmithKline, Cayman Islands; GlaxoSmithKline, Saint Lucia; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Norway; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Trinidad & Tobago; GlaxoSmithKline, South Africa; ViiV, Austria; ViiV, Switzerland; ViiV, United Kingdom; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Italy; ViiV Healthcare ULC, Canada; Viivhiv, Portugal
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
